A Trovato
About
In The Last Decade
A Trovato
15 papers receiving 566 citations
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 202
- Genetics 193
- Pharmacology 184
- Molecular Biology 137
- Oncology 125
Countries citing papers authored by A Trovato
This map shows the geographic impact of A Trovato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Trovato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Trovato more than expected).
Fields of papers citing papers by A Trovato
This network shows the impact of papers produced by A Trovato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Trovato. The network helps show where A Trovato may publish in the future.
Co-authorship network of co-authors of A Trovato
This figure shows the co-authorship network connecting the top 25 collaborators of A Trovato. A scholar is included among the top collaborators of A Trovato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Trovato. A Trovato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 47 | |
| 3 | 84 | |
| 4 | 8 | |
| 5 | 42 | |
| 6 | 1 | |
| 7 | Pasireotide treatment is associated with clinically meaningful improvements in health-related quality of life in Cushing's disease: results from a large, randomized, double-blind phase III trial | 3 |
| 8 | Long-term pasireotide use leads to improvements in the biochemical parameters of Cushing's disease: 24-month results from a randomized phase III study | 4 |
| 9 | Long-term use of pasireotide in Cushing's disease: 24-month safety results from a randomized phase III study | 7 |
| 10 | Pasireotide treatment is associated with improvements in hypertension: 12-month results from a large phase III study in Cushing's disease | 4 |
| 11 | 13 | |
| 12 | 245 | |
| 13 | 102 | |
| 14 | 8 | |
| 15 | [Effects of some prostaglandins on plasma levels of prolactin in the rat]. | 2 |
| 16 | The influence of cannabis on glucoregulation. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.